COMPLEX ADULT HEALTH UPDATED ACTUAL EXAM QUESTIONS CORRECT ANSWERS
GRADED A PLUS
Question:
Albuterol Indiciations.
Answer:
adrenergic used as a bronchodilator to control & prevent reversible airway obstruction caused by
asthma or COPD
Question:
Albuterol Side Effects.
Answer:
nervousness, restlessness, tremor, HA, insomnia (occurs more in children), hyperactivity in
children, paradoxical bronchospasm (due to excessive use of inhales), chest pain, palpitations,
angina, arrhythmias, HPT, N/V, hyperglycemia, hypokalemia, tremor
Question:
Albuterol Interactions.
Answer:
MAOI's lead to hypertensive crisis; beta blockers negate therapeutic effect; decrease digoxin levels;
risk of hypokalemia increases w/use of K+ losing diuretics (hypokalemia increases the risk of
digoxin toxicity); use w/caffeine- containing herbs (cola nut, guarana, tea, coffee) increases
stimulant effect
Question:
Albuterol Nursing Implications.
Answer:
,monitor/report tachycardia, heart palpitations, & chest pain; monitor/report tremors
Question:
Albuterol Patient Teaching.
Answer:
report chest pain & heart palpitations; report increase in pulse rate; avoid caffeine; notify PCP if
tremors interfere with ADLs
Question:
T-PA Indications.
Answer:
tissue plasminogen activator & recombinant approved by the U.S FDA for IV thrombolysis in acute
ischemic stroke w/in 3 hours of onset of stroke symptoms; only approved for PT's 18yo & older
Question:
t-PA.
Answer:
Alteplase
Question:
Albuterol.
Answer:
Ventolin
Question:
T-PA Precautions/Contraindications.
Answer:
,unclear time/unwitnessed symptom onset/last known baseline state greater than 3-4.5 hrs; current or
HX of IC hemorrhage; CT showing hypoattenuation or hypoperfusion representing irreversible
injury; recent (w/in 3 months) ischemic stroke, severe head trauma, or intracranial/intraspinal
surgery; Subarachnoid hemorrhage; GI malignancy or GI bleed within 21 days of stroke event; IC
conditions that may increase risk of bleeding (such as intracranial neoplasm, arteriovenous
malformation, or aneurysm); Coagulopathy; Low molecular weight heparin (LMWH) treatment
doses within the previous 24 hrs; Current use of anticoagulant with INR > 1.7 or PT > 15 seconds;
Current use of direct thrombin inhibitors or direct factor Xa inhibitors w/elevated laboratory tests;
Concurrent use of glycoprotein IIb/IIIa receptor inhibitors; Infective endocarditis; Aortic arch
dissection; Intra-axial intracranial neoplasm - lesions located within the brain tissue
Question:
T-PA Adverse Effects.
Answer:
Bleeding (most common); Orolingual angioedema; Arrhythmias; Hypotension; Edema; Cholesterol
embolization; Venous thrombosis; Re-embolization of deep venous thrombi (DVT) in patients with
pulmonary embolims; Nausea; Vomiting; Hypersensitivity reactions
Question:
T-PA Interactions.
Answer:
Warfarin; aspirin (ASA); NSAID's (Ibuprofen, Naproxen, Nabumetone, and platelet inhibitors such
as- Plavix, Effeint, Kengreal, and Brilinta); BC Alteplase breaks down clots & interferes w/the
body's ability to stop bleeding, any drugs that also interfere w/the body's ability to form blood clots
can increase the risk of bleeding in patients
Question:
T-PA Patient Teaching.
Answer:
must be used w/in 8 hrs of being opened; can alter the test results of coagulation & fibrinolytic
activity tests; have patient immediately report to the PCP any signs of bleeding (vomiting blood or
vomit that looks like coffee grounds; coughing up blood; hematuria; black, red, or tarry stools;
bleeding from the gums; abnormal vaginal bleedings; bruises without a reason or that get better);
, immediately report to the PCP any signs of DVT (edema, warmth, numbness, change in color, or
pain in the extremities); report to PCP any severe cerebrovascular disease (change in strength on 1
side is greater than the other, difficulty speaking or thinking, change in balance, or visual changes)
Question:
Amiodarone.
Answer:
Cordarone
Question:
Amiodarone Indications.
Answer:
class III potassium channel blocker that manages life-threatening ventricular-tachycardia or
fibrillation that's resistant to other drugs; may treat some atrial dysrhythmias, such as atrial
fibrillation
Question:
Amiodarone Contraindications/Precautions.
Answer:
cardiogenic shock; sick sinus syndrome, 2nd- or 3rd-degree AV block, bradycardia leading to
syncope without a functioning pacemaker; any known hypersensitivity to the drug or to any of its
components, including iodine; pulmonary toxicity; hepatic injury; worsened arrhythmia; visual
impairment or loss of vision; thyroid abnormalities; bradycardia; implantable cardiac devices; fetal
toxicity; peripheral neuropathy; photosensitivity & skin discoloration; surgery
Question:
Amiodarone Adverse Effects.
Answer:
N/V; constipation; pulmonary toxicity w/ pneumonitis (causing fever, cough, SOB), occurs most
frequently w/ long-term and/or high-dose use and may lead to pulmonary fibrosis); visual
GRADED A PLUS
Question:
Albuterol Indiciations.
Answer:
adrenergic used as a bronchodilator to control & prevent reversible airway obstruction caused by
asthma or COPD
Question:
Albuterol Side Effects.
Answer:
nervousness, restlessness, tremor, HA, insomnia (occurs more in children), hyperactivity in
children, paradoxical bronchospasm (due to excessive use of inhales), chest pain, palpitations,
angina, arrhythmias, HPT, N/V, hyperglycemia, hypokalemia, tremor
Question:
Albuterol Interactions.
Answer:
MAOI's lead to hypertensive crisis; beta blockers negate therapeutic effect; decrease digoxin levels;
risk of hypokalemia increases w/use of K+ losing diuretics (hypokalemia increases the risk of
digoxin toxicity); use w/caffeine- containing herbs (cola nut, guarana, tea, coffee) increases
stimulant effect
Question:
Albuterol Nursing Implications.
Answer:
,monitor/report tachycardia, heart palpitations, & chest pain; monitor/report tremors
Question:
Albuterol Patient Teaching.
Answer:
report chest pain & heart palpitations; report increase in pulse rate; avoid caffeine; notify PCP if
tremors interfere with ADLs
Question:
T-PA Indications.
Answer:
tissue plasminogen activator & recombinant approved by the U.S FDA for IV thrombolysis in acute
ischemic stroke w/in 3 hours of onset of stroke symptoms; only approved for PT's 18yo & older
Question:
t-PA.
Answer:
Alteplase
Question:
Albuterol.
Answer:
Ventolin
Question:
T-PA Precautions/Contraindications.
Answer:
,unclear time/unwitnessed symptom onset/last known baseline state greater than 3-4.5 hrs; current or
HX of IC hemorrhage; CT showing hypoattenuation or hypoperfusion representing irreversible
injury; recent (w/in 3 months) ischemic stroke, severe head trauma, or intracranial/intraspinal
surgery; Subarachnoid hemorrhage; GI malignancy or GI bleed within 21 days of stroke event; IC
conditions that may increase risk of bleeding (such as intracranial neoplasm, arteriovenous
malformation, or aneurysm); Coagulopathy; Low molecular weight heparin (LMWH) treatment
doses within the previous 24 hrs; Current use of anticoagulant with INR > 1.7 or PT > 15 seconds;
Current use of direct thrombin inhibitors or direct factor Xa inhibitors w/elevated laboratory tests;
Concurrent use of glycoprotein IIb/IIIa receptor inhibitors; Infective endocarditis; Aortic arch
dissection; Intra-axial intracranial neoplasm - lesions located within the brain tissue
Question:
T-PA Adverse Effects.
Answer:
Bleeding (most common); Orolingual angioedema; Arrhythmias; Hypotension; Edema; Cholesterol
embolization; Venous thrombosis; Re-embolization of deep venous thrombi (DVT) in patients with
pulmonary embolims; Nausea; Vomiting; Hypersensitivity reactions
Question:
T-PA Interactions.
Answer:
Warfarin; aspirin (ASA); NSAID's (Ibuprofen, Naproxen, Nabumetone, and platelet inhibitors such
as- Plavix, Effeint, Kengreal, and Brilinta); BC Alteplase breaks down clots & interferes w/the
body's ability to stop bleeding, any drugs that also interfere w/the body's ability to form blood clots
can increase the risk of bleeding in patients
Question:
T-PA Patient Teaching.
Answer:
must be used w/in 8 hrs of being opened; can alter the test results of coagulation & fibrinolytic
activity tests; have patient immediately report to the PCP any signs of bleeding (vomiting blood or
vomit that looks like coffee grounds; coughing up blood; hematuria; black, red, or tarry stools;
bleeding from the gums; abnormal vaginal bleedings; bruises without a reason or that get better);
, immediately report to the PCP any signs of DVT (edema, warmth, numbness, change in color, or
pain in the extremities); report to PCP any severe cerebrovascular disease (change in strength on 1
side is greater than the other, difficulty speaking or thinking, change in balance, or visual changes)
Question:
Amiodarone.
Answer:
Cordarone
Question:
Amiodarone Indications.
Answer:
class III potassium channel blocker that manages life-threatening ventricular-tachycardia or
fibrillation that's resistant to other drugs; may treat some atrial dysrhythmias, such as atrial
fibrillation
Question:
Amiodarone Contraindications/Precautions.
Answer:
cardiogenic shock; sick sinus syndrome, 2nd- or 3rd-degree AV block, bradycardia leading to
syncope without a functioning pacemaker; any known hypersensitivity to the drug or to any of its
components, including iodine; pulmonary toxicity; hepatic injury; worsened arrhythmia; visual
impairment or loss of vision; thyroid abnormalities; bradycardia; implantable cardiac devices; fetal
toxicity; peripheral neuropathy; photosensitivity & skin discoloration; surgery
Question:
Amiodarone Adverse Effects.
Answer:
N/V; constipation; pulmonary toxicity w/ pneumonitis (causing fever, cough, SOB), occurs most
frequently w/ long-term and/or high-dose use and may lead to pulmonary fibrosis); visual
